DE3311008C2 - Öllösliche Zubereitung, die ein fettlösliches Vitamin enthält - Google Patents
Öllösliche Zubereitung, die ein fettlösliches Vitamin enthältInfo
- Publication number
- DE3311008C2 DE3311008C2 DE3311008A DE3311008A DE3311008C2 DE 3311008 C2 DE3311008 C2 DE 3311008C2 DE 3311008 A DE3311008 A DE 3311008A DE 3311008 A DE3311008 A DE 3311008A DE 3311008 C2 DE3311008 C2 DE 3311008C2
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- oil
- soluble
- weight
- butyrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229930003231 vitamin Natural products 0.000 title claims abstract description 33
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 33
- 239000011782 vitamin Substances 0.000 title claims abstract description 33
- 229940088594 vitamin Drugs 0.000 title claims abstract description 33
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title abstract description 28
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 21
- 229930195729 fatty acid Natural products 0.000 claims abstract description 21
- 239000000194 fatty acid Substances 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 14
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 29
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims description 28
- -1 fatty acid ester Chemical class 0.000 claims description 26
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 23
- 239000008158 vegetable oil Substances 0.000 claims description 23
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 17
- 239000003921 oil Substances 0.000 claims description 14
- 235000019198 oils Nutrition 0.000 claims description 14
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract description 26
- 239000000203 mixture Substances 0.000 abstract description 21
- 150000004665 fatty acids Chemical class 0.000 abstract description 15
- 239000011720 vitamin B Substances 0.000 abstract description 13
- 229930003270 Vitamin B Natural products 0.000 abstract description 11
- 235000019156 vitamin B Nutrition 0.000 abstract description 11
- 125000004432 carbon atom Chemical group C* 0.000 abstract description 10
- 150000005691 triesters Chemical class 0.000 abstract description 9
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 abstract description 8
- 150000005690 diesters Chemical class 0.000 abstract description 8
- 229920001214 Polysorbate 60 Polymers 0.000 abstract 2
- 150000002148 esters Chemical class 0.000 abstract 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 description 41
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 9
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 9
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 9
- 239000005642 Oleic acid Substances 0.000 description 9
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 9
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 9
- 235000019484 Rapeseed oil Nutrition 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- 235000011187 glycerol Nutrition 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- 235000019871 vegetable fat Nutrition 0.000 description 5
- LWZFANDGMFTDAV-BURFUSLBSA-N [(2r)-2-[(2r,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O LWZFANDGMFTDAV-BURFUSLBSA-N 0.000 description 4
- 239000010497 wheat germ oil Substances 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 229940045997 vitamin a Drugs 0.000 description 3
- 235000019483 Peanut oil Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000000312 peanut oil Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N n-hexanoic acid Natural products CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000012053 oil suspension Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57091466A JPS58208215A (ja) | 1982-05-31 | 1982-05-31 | 脂溶性ビタミン配合油溶組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3311008A1 DE3311008A1 (de) | 1983-12-01 |
| DE3311008C2 true DE3311008C2 (de) | 1986-04-10 |
Family
ID=14027151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE3311008A Expired DE3311008C2 (de) | 1982-05-31 | 1983-03-25 | Öllösliche Zubereitung, die ein fettlösliches Vitamin enthält |
Country Status (6)
| Country | Link |
|---|---|
| JP (1) | JPS58208215A (enrdf_load_stackoverflow) |
| CH (1) | CH656531A5 (enrdf_load_stackoverflow) |
| DE (1) | DE3311008C2 (enrdf_load_stackoverflow) |
| FR (1) | FR2527440B1 (enrdf_load_stackoverflow) |
| GB (1) | GB2120935B (enrdf_load_stackoverflow) |
| SE (1) | SE461892B (enrdf_load_stackoverflow) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5639724A (en) * | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
| JPS63130535A (ja) * | 1986-11-19 | 1988-06-02 | Nisshin Kagaku Kk | 経口投与用抗ヒスタミン剤 |
| US7081445B2 (en) | 1989-02-20 | 2006-07-25 | Novartis Ag | Cyclosporin galenic forms |
| GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
| SG115386A1 (en) | 1997-01-30 | 2005-10-28 | Novartis Ag | Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR8014M (enrdf_load_stackoverflow) * | 1968-01-09 | 1970-07-27 | ||
| US3962436A (en) * | 1969-06-03 | 1976-06-08 | Sumitomo Chemical Company, Limited | Pharmaceutical compositions having controlled rate of gastro-intestinal absorption |
| NL7012460A (enrdf_load_stackoverflow) * | 1970-08-22 | 1972-02-24 | ||
| US3932634A (en) * | 1973-06-28 | 1976-01-13 | Pfizer Inc. | High potency vitamin water dispersible formulations |
-
1982
- 1982-05-31 JP JP57091466A patent/JPS58208215A/ja active Granted
-
1983
- 1983-03-18 GB GB08307543A patent/GB2120935B/en not_active Expired
- 1983-03-22 SE SE8301565A patent/SE461892B/sv not_active IP Right Cessation
- 1983-03-25 CH CH1664/83A patent/CH656531A5/de not_active IP Right Cessation
- 1983-03-25 DE DE3311008A patent/DE3311008C2/de not_active Expired
- 1983-03-30 FR FR8305239A patent/FR2527440B1/fr not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CH656531A5 (de) | 1986-07-15 |
| FR2527440B1 (fr) | 1987-05-15 |
| DE3311008A1 (de) | 1983-12-01 |
| SE461892B (sv) | 1990-04-09 |
| GB2120935A (en) | 1983-12-14 |
| SE8301565L (sv) | 1983-12-01 |
| GB8307543D0 (en) | 1983-04-27 |
| JPH044299B2 (enrdf_load_stackoverflow) | 1992-01-27 |
| SE8301565D0 (sv) | 1983-03-22 |
| GB2120935B (en) | 1985-10-23 |
| JPS58208215A (ja) | 1983-12-03 |
| FR2527440A1 (fr) | 1983-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE4219526C2 (de) | Pharmazeutisches Mittel | |
| DE69320206T2 (de) | Paclitaxel enthaltende injizierbare zusammensetzung | |
| DE60014162T2 (de) | Fenofibrathaltige galenische arzneizusammensetzungen und verfahren zu ihrer herstellung | |
| DE69012268T2 (de) | Mittel zur Hemmung der alpha-Amylase Aktivität. | |
| DE69033560T2 (de) | Arzneimittel für insulinresistente diabetiker | |
| DE69815659T2 (de) | Zusammensetzung zur kontrollierten freisetzung | |
| DE3042332C2 (enrdf_load_stackoverflow) | ||
| EP0456106B1 (de) | Stabile, zur pharmazeutischen Verabreichung geeignete Emulsion, Verfahren zu deren Herstellung und Emulsion zur Anwendung als Arzneimittel | |
| WO1998035679A1 (de) | Stabilisierung von naloxonhydrochlorid | |
| DE2036114B2 (de) | Wäßriges Tetramisolpräparat | |
| DE3685832T2 (de) | Ubidecarenon enthaltende mittel mit erhoehter absorption. | |
| DE69002697T2 (de) | Carboplatinzusammensetzung. | |
| DE29719704U1 (de) | Stabile Zubereitungen von Naloxonhydrochlorid | |
| DE3311008C2 (de) | Öllösliche Zubereitung, die ein fettlösliches Vitamin enthält | |
| DE2361169C3 (de) | Verfahren zur Aktivierung von von Detengensspuren befreiter Cholesterinoxydase | |
| DE60004191T2 (de) | Gelöste pharmazeutische zusammensetzung für die parenterale verabreichung | |
| EP0319598B1 (de) | Stabilisierte wässrige Folsäurezubereitung | |
| EP0143857A1 (de) | Coronartherapeutikum in Form von Weichgelatine-Kapseln | |
| EP0336000B1 (de) | Ambiphile Creme | |
| DE60220799T2 (de) | Hypoglykämisches mittel | |
| EP0167840A1 (de) | Diätetische Zusammensetzung | |
| DE2534744A1 (de) | Verfahren zur stabilisierung von pfanzlichen oelen, tierischen fetten und arzneimitteln auf der basis von fettloeslichen vitaminen gegen oxydativen abbau | |
| DE3042975A1 (de) | Mikrodispersion mit einem wirkstoff und/oder einem reagens in salzform als disperser phase | |
| EP0176772A1 (de) | Verfahren zur Retardierung von Vitamin C und E | |
| DE2138586C2 (de) | Injektionspräparat mit Vitamin A-Wirksamkeit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OP8 | Request for examination as to paragraph 44 patent law | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition |